![Mirko Scherer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mirko Scherer
Fondatore presso
Charly SpA
Profilo
Dr. Mirko Scherer is a Chief Technology Officer at Charly SpA and a Chief Executive Officer at TVM Capital China Ltd. Dr. Scherer was previously employed as an Independent Non-Executive Director by Aptorum Group Ltd., a Non-Executive Director by Quantapore, Inc., a Co-Managing Director by KI Kapital GmbH, and a Chief Financial Officer by GPC Biotech AG.
He also served on the board at Frankfurt Stock Exchange and Stichting Preferente Aandelen Qiagen.
He received his undergraduate degree from the University of Mannheim, an MBA from Harvard Business School and a doctorate degree from EBS Universität für Wirtschaft und Recht gGmbH.
Posizioni attive di Mirko Scherer
| Società | Posizione | Inizio |
|---|---|---|
Charly SpA
 Charly SpA Packaged SoftwareTechnology Services Offers automated financial advisory platform for startups | Fondatore | 01/03/2016 |
TVM Capital China Ltd. | Amministratore Delegato | 01/03/2015 |
Precedenti posizioni note di Mirko Scherer
| Società | Posizione | Fine |
|---|---|---|
Stichting Preferente Aandelen Qiagen | Direttore/Membro del Consiglio | 01/01/2019 |
Quantapore, Inc.
 Quantapore, Inc. BiotechnologyHealth Technology Develops nanopore based nucleic acid sequencing technology | Direttore/Membro del Consiglio | 01/07/2018 |
KI Kapital GmbH
 KI Kapital GmbH Investment ManagersFinance KI Kapital invests in companies located in Europe. The firm focuses on companies operating across a broad range of sectors and industries. It provides financing for later stage capital requirements. | Corporate Officer/Principal | 01/02/2014 |
GPC Biotech AG
 GPC Biotech AG Miscellaneous Commercial ServicesCommercial Services Discovers, develops and commercializes new anticancer drugs | Fondatore | 04/12/2007 |
Börse Frankfurt
 Börse Frankfurt Investment Banks/BrokersFinance Operates as stock market | Direttore/Membro del Consiglio | 01/01/2007 |
Formazione di Mirko Scherer
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
95
Relazioni di 1° grado
11
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 11 |
|---|---|
GPC Biotech AG
GPC Biotech AG Miscellaneous Commercial ServicesCommercial Services Discovers, develops and commercializes new anticancer drugs | Commercial Services |
University of Mannheim
 University of Mannheim Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EBS Universität für Wirtschaft und Recht gGmbH
 EBS Universität für Wirtschaft und Recht gGmbH Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
KI Kapital GmbH
KI Kapital GmbH Investment ManagersFinance KI Kapital invests in companies located in Europe. The firm focuses on companies operating across a broad range of sectors and industries. It provides financing for later stage capital requirements. | Finance |
Börse Frankfurt
Börse Frankfurt Investment Banks/BrokersFinance Operates as stock market | Finance |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TVM Capital China Ltd. | |
Quantapore, Inc.
Quantapore, Inc. BiotechnologyHealth Technology Develops nanopore based nucleic acid sequencing technology | Health Technology |
Charly SpA
Charly SpA Packaged SoftwareTechnology Services Offers automated financial advisory platform for startups | Technology Services |
Aptorum Group Ltd.
 Aptorum Group Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutic and diagnostic products | Health Technology |
Stichting Preferente Aandelen Qiagen |
